According to a Research Report Published by Spherical Insights and Consulting, The Global Cell and Gene Therapy Market Size was worth around USD 7.70 Billion in 2024, Growing to USD 8.84 Billion in 2025, and is predicted to Grow to around USD 46.70 Billion by 2035 with a compound annual growth rate (CAGR) of 17.81% from 2025 to 2035. The market for cell and gene therapy presents game-changing opportunities due to novel chronic illness therapies, increased production capabilities, strategic alliances, substantial research funding, and regulatory developments that improve accessibility and commercialization.